Contract notice
Section I: Contracting
authority
I.1) Name and addresses
NHS Wales Shared Services Partnership
Cardiff and Vale University Local Health Board, Procurement Services, Woodlands House, Maes-Y-Coed Road
Cardiff
CF14 4HH
UK
Contact person: Emma Lane
Telephone: +44 02921508264
E-mail: emma.lane@wales.nhs.uk
NUTS: UK
Internet address(es)
Main address: http://nwssp.nhs.wales/ourservices/procurement-services/
Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
www.etenderwales.bravosolution.co.uk
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
www.etenderwales.bravosolution.co.uk
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Purchase of Apheresis Machines, ongoing Maintenance and Consumables
Reference number: CAV-OJEU-PROJECT52379
II.1.2) Main CPV code
33100000
II.1.3) Type of contract
Supplies
II.1.4) Short description
The South Wales Blood and Marrow Transplant (SWBMT) Programme serves adults and children in the catchment area of mid, west and south Wales, accounting for nearly 80% of the Welsh population. It consists of a Clinical Programme supported by Collection and Processing Facilities. Of the 53 transplant centres in the UK and Eire, the SWBMT Programme is one of the few whose activities cover the entire spectrum of clinical, collection, processing, and storage services.
The service is delivered across two Local Health Boards – Swansea Bay University Health Board (SBUHB) and Cardiff and Vale University Health Board (CVUHB). The Collection Facility, within which apheresis activity is conducted, is based at CVUHB with adult and paediatric collection units at the University Hospital of Wales and the Children’s Hospital for Wales, respectively.
All apheresis technology must therefore be approved for use in the United Kingdom in both children and adults across the range of services currently provided. The Programme is accredited by JACIE (the Joint Accreditation Committee of the ISCT and EBMT) and licensed by the HTA (Human Tissue Authority), licence number 11094, for all activities pursuant to the Human Tissue (Quality and Safety for Human Application) Regulations 2007 and the Human Tissue Act 2004.
The SWBMT has received capital funding for the purchase of three new Apheresis machines and as such, the NHS Wales Shared Services Partnership (NWSSP), hosted by Velindre NHS Trust are acting on behalf of Cardiff and Vale University Local Health Board who are seeking to establish a contract for the Purchase of three Apheresis Machines as well as ongoing Maintenance. A separate lot is advertised under this Procurement for the supply of the compatible consumables.
II.1.5) Estimated total value
Value excluding VAT:
450 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
Yes
Tenders may be submitted for all lots
II.2) Description
Lot No: 1
II.2.1) Title
Purchase of Apheresis Machines and ongoing Maintenance
II.2.2) Additional CPV code(s)
33100000
II.2.3) Place of performance
NUTS code:
UKL22
II.2.4) Description of the procurement
Under this lot, the Health Board is seeking to award the Purchase of three Apheresis Machines with ongoing Maintenance for 5 years after one year warranty
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 60
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 2
II.2.1) Title
Purchase of Apheresis Consumables
II.2.2) Additional CPV code(s)
33140000
II.2.3) Place of performance
NUTS code:
UKL22
II.2.4) Description of the procurement
Under this lot, the Health Board is seeking to establish a contract for the provision of apheresis consumables
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 24
This contract is subject to renewal: Yes
Description of renewals:
The contract will have an option to extend for up to a further year at the sole discretion of the Health Board which is included in the months duration within this notice.
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
III.2) Conditions related to the contract
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
- Accelerated procedure
Justification:
The Health Board has been allocated capital funding within this financial year only for the purchase of three new Apheresis machines and as such, there is a limited time to complete an urgent Procurement for this requirement.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
09/02/2023
Local time: 16:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 190 (from the date stated for receipt of tender)
IV.2.7) Conditions for opening of tenders
Date:
09/02/2023
Local time: 16:00
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.2) Information about electronic workflows
Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
VI.3) Additional information
Please note additional information on this procurement:
1. The Contracting Authority reserves the right to award the contract in whole, in part, per lot or annul the tendering process and not award any contract.
2. Bidders should note that they will be required to enter into terms and conditions of contract as set out in the tender and that save for matters of clarification or consistency the Contracting Authority will not negotiate the terms.
3. The Contracting Authority will not accept completed tenders after the stated closing date.
4. All documents to be priced (where applicable) in sterling and all payments made in sterling.
5. All tender costs and liabilities incurred by bidders shall be the sole responsibility of the bidders.
6. Prospective suppliers should note that NHS Shared Services Partnership - Procurement Services is acting on behalf of Cardiff and Vale University Local Health Board.
7. Bidders wishing to participate should visit the Bravo e-tenderwales portal and access the itt_100680 for all tender documentation.
NOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on Sell2Wales at http://www.sell2wales.gov.wales/search/search_switch.aspx?ID=128487
(WA Ref:128487)
The buyer considers that this contract is suitable for consortia.
VI.4) Procedures for review
VI.4.1) Review body
VI.4.3) Review procedure
Precise information on deadline(s) for review procedures:
NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract.
Unsuccessful tenderers and applicants are entitled to receive reasons for the decision, including the characteristics and relative advantages of the winning bid and the reasons why the tenderer/applicant was unsuccessful. Should additional information be required it should be requested of the addressee in section I.1. Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits in accordance with the Public Contracts (Amendments) Regulations 2015.
VI.5) Date of dispatch of this notice
26/01/2023